logo
From Ordinary to Extraordinary: The Packaging People's Insights on the Impact of Custom Packaging for Business

From Ordinary to Extraordinary: The Packaging People's Insights on the Impact of Custom Packaging for Business

With the start of a new financial year, businesses are reviewing strategies that support brand differentiation, customer engagement, and long-term growth. Among these strategies, custom packaging is gaining recognition as a critical brand asset, one that goes beyond product protection to deliver measurable marketing value.
Victoria, Australia, July 1, 2025 -- In a saturated and visually competitive marketplace, packaging now functions as a direct expression of a brand's identity. Custom packaging enables products to stand out on shelves, strengthen brand recognition, and reinforce consumer perception.
The Power of Custom Packaging
Custom packaging functions as more than a protective layer; it has become an important marketing tool that contributes directly to brand visibility and recall. Unlike generic packaging, custom designs are developed to reflect a business's identity, values, and target audience. This strategic alignment ensures that packaging supports not only product delivery but also storytelling, consistency, and brand loyalty.
Businesses are increasingly treating packaging as a brand-owned channel, one that supports omnichannel marketing strategies and builds trust through every physical interaction with a product. From artisan producers to large-scale manufacturers, the emphasis is shifting toward packaging that communicates value at first glance.
In the current market, the customer journey extends beyond the point of sale. Unboxing experiences, often shared through video or social media, have become an important aspect of product interaction and peer-to-peer marketing. Packaging that is carefully crafted and visually compelling can prompt customers to share their experiences online, generating user-generated content and expanding reach.
Industry research suggests that consumers are more likely to remember and recommend products that are presented with care. Distinctive packaging contributes to positive brand associations while also supporting digital engagement without additional marketing spend.
Custom packaging also allows brands to better meet the expectations of today's consumers, who often prioritise sustainability, transparency, and thoughtful design. With growing awareness of environmental concerns, packaging that uses recyclable or compostable materials is increasingly viewed as a baseline standard rather than a value-added feature. Brands that tailor their packaging to reflect these values are more likely to earn long-term loyalty and differentiate themselves in a competitive market.
The Packaging People reports increased demand for packaging solutions that balance visual appeal with environmental responsibility. By aligning materials, finishes, and structural design with both brand identity and consumer preferences, packaging becomes a tool for value-driven communication.
A New Financial Year, A New Packaging Opportunity
The beginning of the financial year presents a timely opportunity for businesses to reassess their brand presence and market approach. Whether launching new products, repositioning existing ones, or looking to strengthen visibility, custom packaging offers a scalable way to evolve the customer experience.
As packaging becomes more central to the brand narrative, businesses are increasingly incorporating it into broader marketing and operational strategies. Brands investing in packaging innovation early in the financial year are better positioned to maximise return across seasonal campaigns, product launches, and retail cycles.
As businesses navigate an evolving retail landscape, custom packaging is proving to be a key driver of perceived value, brand engagement, and consumer retention. It is no longer just a finishing touch; it's a growth-enabling tool that supports lasting market differentiation.
About the company: The Packaging People is a leading Australian supplier of sustainable and custom packaging solutions, with a focus on the food and beverage industry. The company partners with brands nationwide to deliver packaging that enhances shelf presence and strengthens brand recognition.
Contact Info:
Name: The Packaging People
Email: Send Email
Organization: The Packaging People
Website: https://thepackagingpeople.com.au/
Release ID: 89163583
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hyatt to Debut The Unbound Collection in Thailand
Hyatt to Debut The Unbound Collection in Thailand

Skift

time29 minutes ago

  • Skift

Hyatt to Debut The Unbound Collection in Thailand

CBRE's second annual Top 10 Hotel Owners and Operators Report for Australia and New Zealand benchmarks the largest hotel groups by room counts and also introduces exclusive sentiment insights from senior executives across the sector. On the owners' side, Meriton retains the top spot with 6,211 rooms despite slowing growth and a reduced pipeline. CBRE said Millennium and Copthorne advanced one place to 7th position, expanding their portfolio to 18 hotels and 3,148 rooms. Accor remains the dominant operator, managing 65,075 rooms, more than four and a half times the next largest operator. Accor expanded its network by almost 1,700 rooms and added five hotels, bringing its total footprint to 406 properties. EVT and Meriton appear on both the Top 10 Owners and Operators lists. In terms of industry sentiment, CBRE said 82% of executives expressed a somewhat optimistic outlook for the second half of 2025 and into 2026. 64% said they plan to expand their portfolios through

Santos flags delay in $18.7bn takeover bid by ADNOC-led consortium
Santos flags delay in $18.7bn takeover bid by ADNOC-led consortium

Yahoo

timean hour ago

  • Yahoo

Santos flags delay in $18.7bn takeover bid by ADNOC-led consortium

Australia's second-largest independent gas producer, Santos, has announced a delay in the $18.7bn takeover bid by an Abu Dhabi National Oil Company (ADNOC)-led consortium, extending the exclusive due diligence period by at least one month past the initial deadline, as reported by Reuters. The consortium, which includes Abu Dhabi Development Holding Company (ADQ) and Carlyle, is said to have informed Santos that additional time is required to secure all necessary approvals for formalising the bid. The consortium's proposed offer of A$8.89 per share has been under scrutiny, with Santos shares trading below the proposed value since the announcement on 16 June. Despite the delay, ADNOC's international investment arm, XRG, stated that the consortium will continue due diligence and negotiations. The enterprise value of Santos, including net debt, would reach A$36.4bn, potentially marking the largest all-cash corporate buyout in Australian history, as per FactSet data. Rystad Energy Gas and LNG Research vice-president Kaushal Ramesh was quoted by the news agency as saying: "This was never going to be an easy transaction to pull off with the confluence of domestic energy security and national interest considerations as well as the multitude of hard to please stakeholders involved.' Regulatory approvals from Australia, Papua New Guinea and the US are essential for the deal to proceed, given Santos' asset distribution across these jurisdictions. Jamie Hannah, deputy investment director at Santos shareholder Van Eck, said: "I don't think (the delay) is going to change the overall risk to the takeover, and that is still the Foreign Investment Review Board. I think that is probably the biggest risk to the whole takeover.' Australia's gas market is under political scrutiny, with warnings of a potential gas shortfall in the eastern states by 2028. Santos' long-delayed Narrabri gas project in New South Wales is seen as a solution to this impending issue. In the previous year, Woodside and Santos were engaged in $52bn merger talks, which ultimately failed. Woodside chief executive Meg O'Neill stated Woodside's lack of interest in a rival bid. If the current bid is successful, the consortium would receive control of two Australian liquefied natural gas (LNG) operations and assets in Papua New Guinea, including the prized PNG LNG and Papua LNG projects. The two Australian LNG operations are Gladstone LNG and Darwin LNG. Santos is also progressing with its Alaskan oil project, Pikka, which is set to commence production in mid-2026. In the meantime, Santos has postponed its interim earnings report to 25 August from the initially planned 20 August. "Santos flags delay in $18.7bn takeover bid by ADNOC-led consortium" was originally created and published by Offshore Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

CSL slashes 15% of workforce and offshoots vaccine division
CSL slashes 15% of workforce and offshoots vaccine division

Yahoo

timean hour ago

  • Yahoo

CSL slashes 15% of workforce and offshoots vaccine division

Australia's largest pharmaceutical company CSL will reduce its headcount by 15% and spin off its vaccine division in response to an 'unprecedented level of challenge and volatility'. CSL expects a one-off, pre-tax restructuring cost hit of $700m-$770m in the 2026 financial year. The company has conducted a series of changes across its research & development (R&D) department, operating model, and plasma network. For example, the company closed 22 underperforming plasma centres in August 2025. CSL did not disclose the areas of the company from where the 15% reduction in employee base would be initiated. As of 2024, CSL employs 32,000 people globally. The initiatives are expected to lead to savings of $500m-$550m progressively over the next three years, with the majority achieved by the end of the 2027 financial year. CSL said it would redirect the funds to 'high priority opportunities'. While most of CSL's revenue comes from its blood plasma treatments for rare illnesses, the pharma company is also one of the world's largest influenza vaccine manufacturers. It supplies more than 130 million doses of seasonal influenza doses globally each year in its Afluria, Fluad and Flucelvax brands. CSL also announced a planned spin-off of its vaccine division, known as CSL Seqirus. The company did not disclose a valuation for the demerger, which is slated to be completed in early 2026 and produce a publicly listed company in Australia, but CEO Dr Paul McKenzie said it would help 'reshape and simplify the [core] business'. Profit in the vaccine unit dipped due to reduced demand in the US – a revenue area the company hopes to address in 2026. "We firmly believe that a simplified and focused CSL is best for patients, best for our people, and best for our shareholders,' McKenzie added. The company said it would also buy back A$750m ($486.50m) of shares this financial year, partaking in a wider trend of share buybacks across the global pharma industry. Sanofi and Eli Lilly are both undertaking billion-dollar share buyback programmes. The significant restructuring, announced on CSL's 2025 financial year earnings report, eclipsed what was a positive year for the company. Net profit after tax was $3bn for the past 12 months up to June 2025, a rise of 15% on constant currencies. CSL's headcount reduction and vaccine spinoff dragged shares down 9.5%, from A$271.32 at market close on 18 August to A$245.45 at market open on 19 August. The Australian-listed company has a market cap of A$109.1bn, making it the country's fifth-largest company. In regard to impacts from tariffs, McKenzie said CSL's strategic initiatives would not be impacted due to its heavy US manufacturing presence. His statement echoed wider sentiment shared by big pharma company execs in the Q2 earnings window, many of whom expect minimal impact. Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "CSL slashes 15% of workforce and offshoots vaccine division" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store